Cronos Group Inc. Common Share

Sep 15, 2026

Cronos to Host 2026 Investor Day at its Cronos GrowCo Facility in Kingsville, Ontario

Cronos Group Inc. will host its inaugural Investor Day on September 24, 2026, at its Cronos GrowCo facility in Kingsville, Ontario. The event will feature a fireside chat with key executives and a tour of the state-of-the-art greenhouse. Webcast registration is open, and a recording will be available for 12 months post-event.

Sep 2, 2026

Cronos’ brand Spinach® Expands its Best-Selling Lineups of Edibles and Vapes

Cronos Group Inc. is expanding its Spinach brand with new edible multipacks and vape flavors. The SOURZ by Spinach Blue Raspberry Lemonade Fully Blasted multipack features the brand's first live resin gummy. Additionally, new vape flavors Strawberry Banana and Sweet Citrus Punch are being introduced. These products will initially be available in Ontario, with broader distribution planned for later this fall.

Cronos Group Reports 2026 Second Quarter Results

Cronos Group reported impressive financial results for Q2 2026, with a 51% year-over-year increase in net revenue, driven by strong sales in Canada and international markets. The company achieved record gross profit and Adjusted EBITDA, highlighting the success of its Spinach® and PEACE NATURALS® brands. However, Cronos faces challenges from ongoing investigations in Israel and rising operating expenses.

Jul 21, 2026

Cronos’ SOURZ by Spinach® Expands its Lineup of Edibles

Cronos Group Inc. is expanding its SOURZ by Spinach® Fully Blasted multipacks to cater to the rising consumer demand for edibles during summer. The new lineup includes popular flavors and a limited-time offer. The brand continues to lead the Canadian edible market with significant market share, reflecting its strong consumer loyalty.

Jul 16, 2026

Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026

Cronos Group Inc. will hold its 2026 second quarter earnings conference call on August 6, 2026, at 8:30 a.m. ET. Senior management will discuss financial results and answer questions from investors. Participants are encouraged to register online and join the call early. The call will also be available for replay on the company's website.

Jun 30, 2026

Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada

Cronos Group Inc. has appointed ATB Capital Markets Corp. as its broker for share repurchases, replacing Virtu Canada Corp. This decision is part of Cronos' ongoing share repurchase program. The company aims to enhance its market presence while focusing on innovation and consumer experience in the cannabis sector.

Jun 22, 2026

Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders

Cronos Group Inc. held its Annual Meeting of Shareholders on June 18, 2026, where 72.24% of shareholders participated. All nominated directors were elected with over 93.6% approval. An advisory resolution on executive compensation received 99.09% support, and Davidson & Company LLP was appointed as the independent auditor for fiscal year 2026.

Jun 16, 2026

Cronos Announces Extension of Share Repurchase Program to the Toronto Stock Exchange

Cronos Group Inc. has announced an extension of its share repurchase program, now accepted by the Toronto Stock Exchange. The program allows for the repurchase of up to $50 million in common shares, with purchases expected to begin on June 19, 2026. Additionally, Cronos received an exemption from the Ontario Securities Commission to facilitate repurchases on U.S. markets.

Cronos Group Reports 2026 First Quarter Results

Cronos Group reported a remarkable 40% increase in net revenue for Q1 2026, reaching $45.2 million. The company achieved record gross profit and maintained its leading market position in Canada, particularly with its Spinach brand in the vape category. Internationally, Cronos saw significant growth, especially in Israel. However, the company faces challenges with rising operating expenses and the pending acquisition of CanAdelaar, which requires regulatory approval.

May 6, 2026

Cronos Expands Pre-Roll Portfolio with Spinach STIX®

Cronos Group Inc. has announced the expansion of its Spinach STIX pre-rolls into more provinces in Canada. This new cylindrical-style pre-roll is designed to cater to the growing consumer interest in portable and consistent smoking options. The pre-roll category is significant in the Canadian market, contributing to over 33% of retail sales. Cronos aims to enhance its product lineup to meet evolving consumer preferences.

Apr 29, 2026

Cronos Group Inc. to Hold Virtual 2026 Annual Meeting of Shareholders

Cronos Group Inc. will host its 2026 Annual Meeting of Shareholders on June 18, 2026, at 11:00 a.m. ET in a virtual-only format. This allows registered shareholders and proxyholders to participate online, ask questions, and vote regardless of location. Detailed instructions and a proxy statement are available on the company's website.

Apr 20, 2026

Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026

Cronos Group Inc. will host its 2026 first quarter earnings conference call on May 11, 2026, at 8:30 a.m. ET. The senior management team will present the company's financial results and answer questions from investors. Participants are encouraged to register in advance and can access a replay of the call on the company's website.

Mar 16, 2026

Cronos Group Inc. to Speak at the 38th Annual ROTH Conference

Cronos Group Inc. announced that its Chairman, President, and CEO, Mike Gorenstein, will speak at the 38th Annual ROTH Conference on March 23, 2026. The event will be accessible via a live webcast on the company's investor relations website. Cronos is recognized for its commitment to cannabis research and developing a diverse brand portfolio.

Feb 26, 2026

Cronos Group Reports 2025 Fourth Quarter and Full-Year Results

Cronos Group reported record net revenue of $44.5 million for Q4 2025, marking a 47% year-over-year increase, and $146.6 million for the full year, a 25% increase. The company attributes this growth to strong demand for its brands and the expansion of Cronos GrowCo. However, it faced a net loss in Q4 2025, contrasting with a profit in the same quarter of 2024, primarily due to increased operating expenses and supply challenges in Canada. The pending acquisition of CanAdelaar is expected to enhance its market presence in Europe.

Feb 17, 2026

Cronos Launches New All-in-One Vape, Spinach PUFFERZ™

Cronos Group Inc. has launched its new all-in-one vape, Spinach PUFFERZ™, designed for cannabis consumers. This innovative device features high-quality cannabis infused with liquid diamonds and offers a range of user-friendly features. Available initially in Alberta, British Columbia, and Ontario, it will be rolled out nationally by April 2026. The launch reflects Cronos' commitment to product quality and brand loyalty.

Feb 12, 2026

Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2026

Cronos Group Inc. will hold its fourth quarter and full-year earnings conference call on February 26, 2026, at 8:30 a.m. ET. The senior management team will discuss financial results and answer questions from investors. Participants can register online and are encouraged to join early. The call will be archived for later access.

Dec 9, 2025

▲ +8.9%on this news· ran to +32% by day 3

Document Cronos to enter the Netherlands with acquisition of Europe's largest adult-use cannabis company Cronos to acquire CanAdelaar for up-front cash consideration of US$67.0M 1 plus cash earnout of 0.5x normalized EBI

Cronos Group Inc. is set to acquire CanAdelaar B.V., the largest adult-use cannabis company in the Netherlands, for an upfront cash payment of $67 million. This acquisition positions Cronos as the market leader in the Netherlands' cannabis industry, which is regulated under the Wietexperiment pilot program. The transaction includes additional contingent payments based on CanAdelaar's future earnings, further supporting Cronos' expansion strategy in Europe. The acquisition is expected to finalize in early 2026, pending regulatory approvals.

Nov 6, 2025

Cronos Group Reports 2025 Third Quarter Results

Cronos Group reported strong financial results for Q3 2025, achieving record levels in net revenue, gross profit, and adjusted EBITDA. The company's performance was bolstered by continued success in Israel, where its PEACE NATURALS brand leads the market. Despite facing temporary supply constraints in Canada, Cronos maintains a robust balance sheet with significant cash reserves, positioning it well for future growth.

Oct 28, 2025

Cronos Brings Back Popular, Limited-Edition Spinach® Green Apple-Flavored Products for the Fall Season

Cronos Group Inc. has reintroduced its limited-edition Caramel Green Apple gummies for the fall season, following last year's success. The company is also expanding its offerings with two new seasonal products. These items are now available across Canada, aiming to enhance consumer engagement during the autumn months.

Oct 23, 2025

Cronos Group Inc. to Hold 2025 Third Quarter Earnings Conference Call on November 6, 2025

Cronos Group Inc. will host its third quarter earnings conference call on November 6, 2025, at 8:30 a.m. ET. The call will feature discussions on the company's financial results, followed by a Q&A session with senior management. Participants are encouraged to register in advance for the call.

Oct 9, 2025

Cronos launches SOURZ by Spinach® Fully Blasted Multipacks

Cronos Group Inc. has launched SOURZ by Spinach® Fully Blasted Multipacks, featuring liquid diamond-infused gummies in popular flavors. This new format aims to provide consumers with greater choice and convenience. The product is now available in various Canadian provinces, reinforcing SOURZ's position as a leading cannabis edible brand.

Aug 7, 2025

▲ +8.1%on this news· ran to +22% by day 3

Cronos Group Reports 2025 Second Quarter Results

Cronos Group reported significantly improved second quarter results for 2025, with net revenue of $33.5 million, up 21% from last year, primarily due to increased sales in Israel and other international markets. The company's strong performance in the medical cannabis sector in Israel contributed to these results, alongside the successful consolidation of Cronos GrowCo. However, a notable net loss of $38.5 million highlights challenges like currency fluctuations and supply constraints in Canada. Despite these issues, Cronos maintains a strong financial position with substantial cash reserves to support its growth strategy.

Jul 2, 2025

Cronos Grows its International Footprint in Switzerland

Cronos Group Inc. is expanding its PEACE NATURALS medical cannabis brand into Switzerland through a partnership with Dascoli Pharma AG. This collaboration will allow Cronos to leverage Dascoli's established distribution network to better serve Swiss patients. The move is part of Cronos's broader strategy to grow its international presence in emerging medical cannabis markets.

Jun 23, 2025

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders

Cronos Group Inc. held its Annual Meeting of Shareholders on June 20, 2025, with 71.87% of shares voted. All nominated directors were elected with over 92.3% approval. Shareholders also supported an advisory resolution on executive compensation with 94.13% approval and appointed Davidson & Company LLP as the independent auditor for 2025.

Jun 2, 2025

Cronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Consumer Conference

Cronos Group Inc. will be represented by CEO Mike Gorenstein at the TD Cowen 9th Annual Future of the Consumer Conference on June 4, 2025. The event will be accessible via a live webcast on the company's investor relations website. Cronos is committed to advancing cannabis research and building a strong brand portfolio.

Cronos Group Reports 2025 First Quarter Results

Cronos Group Inc. reported strong Q1 2025 results, with net revenue increasing by 28% from the previous year, driven largely by sales of cannabis flower and extracts. The company's PEACE NATURALS® brand continues to dominate the Israeli market, while their Spinach® brand ranks highly in Canada. Despite challenges from supply limitations affecting product availability, Cronos is focused on expanding its operations and has authorized a $50 million share repurchase plan. These efforts aim to support growth amid increasing demand in the global cannabis market.

Jun 21, 2024

Cronos Group Inc. Announces Results of 2024 Annual Meeting of Shareholders

Cronos Group Inc. held its Annual Meeting of Shareholders on June 20, 2024, where 71.75% of common shares were represented. All nominated directors were successfully elected with significant majority votes exceeding 93.4%. Shareholders also approved an advisory resolution on executive compensation with 96.19% approval. The meeting was adjourned to allow for the identification of a successor independent auditor, with a reconvened meeting planned to vote on this appointment.

Cronos Group Reports 2023 Fourth Quarter and Full-Year Results

Cronos Group reported its financial results for the fourth quarter and full year of 2023, highlighting an increase in net revenue and cash reserves. The company's consolidated net revenue rose by 9% in Q4 compared to the previous year, driven mainly by higher sales in Canada and entry into international markets like Australia and Germany. Despite these gains, the company faced challenges such as lower sales in Israel due to regional conflicts and pricing pressures impacting overall profitability. The launch of the Lord Jones® brand in Canada has shown promise, supporting the company's strategic growth objectives for 2024.

Cronos Enters Australian Cannabis Market

Cronos Group Inc. is expanding its footprint into the Australian cannabis market by initiating shipments of cannabis flower to Vitura Health Limited. This marks a significant milestone for the company as it aims to enter and expand within international markets. With growing approvals for medical cannabis patients in Australia, Cronos intends to leverage its experience from markets like Canada and Israel to enhance Vitura's market share. The partnership focuses on providing high-quality cannabis products while navigating competition in this emerging market space.

May 31, 2023

Document Cronos Group Announces Streamlined Operating Structure to Improve Cash Flow Plans to Exit Existing U.S. hemp-derived CBD Operations Intends to Launch Lord Jones Brand in the Canadian Adult-use Market in Q4 2023

Cronos Group announces a streamlined operating structure aimed at enhancing cash flow by exiting its U.S. hemp-derived CBD operations by the end of Q2 2023. The company plans to consolidate its financial reporting and increase its cost savings target to $20-$25 million. Additionally, Cronos intends to launch its Lord Jones brand in Canada in Q4 2023. The strategic move is designed to position Cronos favorably for future opportunities in the U.S. THC market as regulatory conditions evolve.

Cronos Group Reports 2023 First Quarter Results Industry-leading balance sheet with $836 million in cash and short-term investments Targeting positive cash flow in 2024 Net revenue in Canada increased 6% in Q1 2023 compa

Cronos Group reported a decrease in consolidated net revenue for Q1 2023, amounting to $20.1 million, a 20% decline from the previous year. While net income loss improved compared to Q1 2022, challenges such as lower cannabis flower sales and increased pricing pressures affected overall performance across its segments. The company holds a robust balance sheet with $836 million in cash and short-term investments and aims for positive cash flow in 2024. Despite challenges in the international markets, particularly in Israel, Cronos remains optimistic about future regulatory changes and product offerings.

Feb 28, 2023

Financial Results (in thousands of USD) Three months ended December 31, Change Year ended December 31, Change 2022 2021 $ % 2022 2021 $ % Net revenue United States $ 854 $ 3,106 $ (2,252) (73) % $ 5,155 $ 9,874 $ (4,719)

Cronos Group Inc. reported its 2022 fourth quarter and full-year financial results, highlighting a 23% increase in consolidated net revenue compared to 2021. Despite a significant drop in U.S. sales, the company observed strong growth in Israel, where net revenue soared by 128%. The success of the Spinach brand, which became the top edible brand in Canada, marks a notable achievement for the company. Operational cost-saving measures led to a $28.7 million reduction in expenses, which is expected to continue into 2023.

Financial Results (in thousands of USD) Three months ended September 30, Change Nine months ended September 30, Change 2022 2021 $ % 2022 2021 $ % Net revenue United States $ 514 $ 2,100 $ (1,586) (76) % $ 4,301 $ 6,768

Cronos Group Reports 2022 Third Quarter Results Reported consolidated net revenue increased 3% year-over-year to $20.9 million; on a constant currency basis, consolidated net revenue increased 7% year-over-year to $21.8 million Reported net revenue in Israel increased 88% year-ov

Jun 14, 2021

Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company Investment is Expected to Position Cronos Group to Benefit from Rapid Growth in the U.S. Cannabis Market PharmaCann is Well Posit

Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company Investment is Expected to Position Cronos Group to Benefit from Rapid Growth in the U.S. Cannabis Market PharmaCann is Well Positioned in Limited License States Across the Midwest and No

Jun 4, 2021

Cronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Begins Commercial Production of CBG BOSTON and TORONTO

Cronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Begins Commercial Production of CBG BOSTON and TORONTO - June 4, 2021 - Cronos Group Inc. (NASDAQ CRON) (TSX CRON) ("Cronos Group"), an innovative global ca

Sep 9, 2020

Cronos Group Announces Expanded Leadership Structure to Drive Next Phase of Growth 30-Year CPG Executive Kurt Schmidt Joins Cronos as Chief Executive Officer and Mike Gorenstein Named Executive Chairman TORONTO

Cronos Group Announces Expanded Leadership Structure to Drive Next Phase of Growth 30-Year CPG Executive Kurt Schmidt Joins Cronos as Chief Executive Officer and Mike Gorenstein Named Executive Chairman TORONTO, September 9, 2020 - Cronos Group Inc. (NASDAQ CRON) (TSX CRON) ("C

Mar 30, 2020

NOTICE TO READER As of

As of June 30, 2019, Cronos Group Inc. (the "Company") determined that it no longer qualified as a "foreign private issuer" as such term is defined in Rule 405 under the Securities Act of 1933, which means that the Company, as of January 1, 2020, has been required to comply with

Mar 30, 2020

Cronos Group Inc.

Cronos Group Inc. ("Cronos Group" or the "Company") has restated its unaudited condensed interim consolidated financial statements for the three months ended March 31, 2019, the six months ended June 30, 2019, and the three and nine months ended September 30, 2019, which were pre

Mar 30, 2020

Amended and Restated Condensed Interim Unaudited Consolidated Financial Statements

Amended and Restated Condensed Interim Unaudited Consolidated Financial Statements For the Three Months Ended March 31, 2019 and March 31, 2018 (In thousands of Canadian dollars) Cronos Group Inc. ("Cronos Group" or the "Company") has restated its unaudited condensed interim c

Nov 12, 2019